Validations: Exception Handling & Rework Controls
Damaged Codes: Reprint, Relabel, or Scrap Damaged Codes: Reprint, Relabel, or Scrap In the pharmaceutical industry, the integrity of product identification through serialization and aggregation is paramount for compliance with regulations such as the US Drug Supply Chain Security Act (DSCSA) and the EU Falsified Medicines Directive (FMD). However, damaged or illegible codes on packages create significant challenges. This article…
De-Aggregation Scenarios: Case and Pallet In today’s pharmaceutical supply chain, maintaining data integrity and compliance with regulations such as DSCSA compliance in the United States, and the EU FMD requirements is critical. Effective management of serialization and aggregation processes goes beyond initial implementation; it involves rigorous validation and exception handling during de-aggregation scenarios. This article provides a detailed step-by-step tutorial…
Returns and Reverse Logistics: Serialization Hooks Returns and Reverse Logistics: Serialization Hooks Understanding Serialization and Aggregation in Pharmaceutical Logistics The pharmaceutical industry’s commitment to compliance and safety is encapsulated in its rigorous serialization and aggregation processes. Serialization uniquely identifies each saleable unit of prescription medication, a necessity driven by regulations like the Drug Supply Chain Security Act (DSCSA) in the…
Decommissioning Reasons & Evidence Decommissioning Reasons & Evidence in Serialization and Aggregation In the pharmaceutical and biopharmaceutical industries, serialization and aggregation are pivotal processes aimed at enhancing supply chain integrity and compliance with regulatory mandates such as the Drug Supply Chain Security Act (DSCSA) and European Falsified Medicines Directive (EU FMD). A critical aspect of these processes involves understanding decommissioning…
Suspect/Illegitimate Product Workflows: A Comprehensive Guide Understanding Serialization and its Implications Serialization has emerged as a critical aspect of pharmaceutical supply chain integrity. As part of the Drug Supply Chain Security Act (DSCSA), serialization involves assigning a unique identifier to each saleable unit of prescription products. This process not only facilitates product traceability but also enhances safety, particularly in mitigating…
Exception Taxonomy: What Counts, What Doesn’t The implementation of serialization and aggregation practices in the pharmaceutical industry is no longer optional but a necessity driven by regulatory requirements such as the Drug Supply Chain Security Act (DSCSA) in the United States and the EU Falsified Medicines Directive (FMD) in Europe. To navigate these complex regulations effectively, professionals must understand both…
False Rejects vs Real Errors: Decision Rules for Serialization and Aggregation Understanding Serialization and Aggregation in Pharmaceutical Supply Chains Serialization and aggregation are critical components of pharmaceutical supply chain management, particularly in the context of compliance with regulations like the Drug Supply Chain Security Act (DSCSA) in the US and the EU Falsified Medicines Directive (EU FMD) in the European…